GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
134 hedge funds and large institutions have $1.03B invested in Global Blood Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 64 increasing their positions, 25 reducing their positions, and 18 closing their positions.
Holders
134
Holders Change
+18
Holders Change %
+15.52%
% of All Funds
3.35%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
37
Increased
64
Reduced
25
Closed
18
Calls
$14M
Puts
$9.27M
Net Calls
+$4.73M
Net Calls Change
-$850K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$58.5M |
| 2 |
O
2
OrbiMed
New York
|
$59.4M |
| 3 |
3
Janus Henderson Group
London,
United Kingdom
|
$26.9M |
| 4 |
4
BlackRock
New York
|
$93.1M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$39.5M |
